Entropy Technologies’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.2M Buy
+60,283
New +$5.36M 0.17% 172
2026
Q1
– Sell
-39,425
Closed -$3.36M – 975
2025
Q4
$3.36M Buy
+39,425
New +$3.24M 0.18% 158
2025
Q1
– Sell
-14,344
Closed -$1.06M – 790
2024
Q4
$1.06M Sell
14,344
-17,004
-54% -$1.19M 0.11% 260
2024
Q3
$2.07M Buy
+31,348
New +$2.28M 0.22% 133
2024
Q1
– Sell
-23,017
Closed -$1.76M – 764
2023
Q4
$1.76M Buy
+23,017
New +$1.6M 0.33% 89

Other funds holding EW

Entropy Technologies's EW Position: Q3 2026 in Review

Entropy Technologies opened a new position in Edwards Lifesciences (EW) in Q3 2026: 60,283 shares worth $5.2M. The stake represents 0.17% of the portfolio and ranks #172 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in EW as recently as Q4 2025.

Entropy Technologies first reported a position in EW in Q4 2023 and has held it in 5 quarters since. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Entropy Technologies held 60,283 shares of Edwards Lifesciences worth $5.2M as of Q3 2026.
  • Edwards Lifesciences was a new Entropy Technologies position in Q3 2026.
  • Edwards Lifesciences made up 0.17% of Entropy Technologies's portfolio in Q3 2026, its #172 holding.
  • Entropy Technologies first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 5 quarters since.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.